Circulating visfatin concentrations in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis
ObjectiveThe current study was designed with the aim of conducting a systematic review and meta-analysis to determine the circulating levels of visfatin in patients with chronic obstructive pulmonary disease (COPD) compared to healthy individuals.MethodsUntil March 2024, we searched the Web of Scien...
Autores principales: | Nahid Aboutaleb, Alireza Moradi, Hamzeh Mirshekari Jahangiri, Mohammad Reza Aslani |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2025-01-01
|
Colección: | Frontiers in Medicine |
Materias: | |
Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1432025/full |
Ejemplares similares
-
Serum levels of visfatin, sirtuin-1, and interleukin-6 in stable and acute exacerbation of chronic obstructive pulmonary disease
por: Hassan Ghobadi, et al.
Publicado: (2021-01-01) -
Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin
por: Anna Maria Cybulska, et al.
Publicado: (2025-02-01) -
Circulating endothelial cells and serum visfatin are indicators of cardiovascular disease risk in psoriasis patients
por: Lamia Elgarhy, et al.
Publicado: (2016-03-01) -
Tissue Expression of Visfatin in Psoriatic Patients
por: Abd El-Aziz El-Rifaie, et al.
Publicado: (2022-10-01) -
Breastfeeding effects on visfatin levels in postpartum women
por: Ching-Ju Shen, et al.
Publicado: (2015-06-01)